A Lipoylation–PDH–TCA Transcriptional Deficit in the Alzheimer’s Disease Cortex — Donor-level Multi-cohort Evidence with Neuronal-composition, Disease-specificity and Matched-null Controls
Journal of Molecular Neuroscience · 17.09.2026 · 76 (4)
DOI: 10.1007/s12031-026-02598-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Neuroscience, online erschienen am 17.09.2026. Verfasst von Tao Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang Uygur Autonomous Region, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurons, Prefrontal Cortex, Citric Acid Cycle. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Demenz
Abstract (Originalsprache)
Cuproptosis, a copper-dependent form of regulated cell death acting through lipoylated tricarboxylic acid (TCA) cycle proteins, has been proposed as a molecular link between type 2 diabetes and Alzheimer’s disease. We asked whether cuproptosis effector genes are dysregulated in a cell-type-specific manner in the human Alzheimer’s disease cortex, and whether any such signal survives controls for neuronal composition and disease specificity. Single-nucleus data from 21 prefrontal cortex donors were aggregated to donor-level pseudobulk within each cell type. Four independent bulk cohorts, each contributing one observation per donor, entered a random-effects meta-analysis. Adjustment for estimated neuronal content, competitive and expression-matched null gene-set testing, and comparison against Huntington’s disease and vascular dementia were applied as controls. The donor was the unit of replication throughout. No gene–cell-type pair survived correction across the 75 prespecified tests; PDHA1 in inhibitory neurons showed the largest nominal reduction (− 0.418, q = 0.829). In donor-level meta-analysis PDHA1 was lower in Alzheimer’s disease in all four cohorts (− 0.457, 95% CI − 0.712 to − 0.201, I^2 = 0%) but did not survive correction (q = 0.086). A post hoc lipoylation/pyruvate dehydrogenase/TCA module did reach the adjusted threshold (− 0.245, 95% CI − 0.363 to − 0.127, q = 0.035), whereas the copper modules pooled to zero and moved in opposite directions across cohorts. Comparable reductions occurred in Huntington’s disease and vascular dementia, and the disease-control contrasts were not significant. These transcriptional associations do not demonstrate cuproptosis, are not specific to Alzheimer’s disease, and are hypothesis-generating only.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang Uygur Autonomous Region, China.
- Xinjiang Medical University, Urumqi, 830011, Xinjiang Uygur Autonomous Region, China.
- Health Management Research Institute and College of Health Management, Xinjiang Medical University, No. 393 Xinyi Road, Urumqi, 830011, Xinjiang Uygur Autonomous Region, China. 694427710@qq.com.
Zitieren
APA
Zhang, T., Chen, X., Wang, Y., & Wang, Y. (2026). A Lipoylation–PDH–TCA Transcriptional Deficit in the Alzheimer’s Disease Cortex — Donor-level Multi-cohort Evidence with Neuronal-composition, Disease-specificity and Matched-null Controls. Journal of Molecular Neuroscience, 76(4). https://doi.org/10.1007/s12031-026-02598-7
Vancouver
Zhang T, Chen X, Wang Y, Wang Y. A Lipoylation–PDH–TCA Transcriptional Deficit in the Alzheimer’s Disease Cortex — Donor-level Multi-cohort Evidence with Neuronal-composition, Disease-specificity and Matched-null Controls. Journal of Molecular Neuroscience. 2026;76(4). doi:10.1007/s12031-026-02598-7
BibTeX
@article{Zhang2026,
author = {Zhang, Tao and Chen, Xiaodong and Wang, Yi and Wang, Yu},
title = {A Lipoylation–PDH–TCA Transcriptional Deficit in the Alzheimer’s Disease Cortex — Donor-level Multi-cohort Evidence with Neuronal-composition, Disease-specificity and Matched-null Controls},
journal = {Journal of Molecular Neuroscience},
year = {2026},
volume = {76},
number = {4},
doi = {10.1007/s12031-026-02598-7}
}
EUVIMED